# the No-reflow in Diabetic Patients Treated With Primary Percutaneous Coronary Intervention (PCI)

> **NCT04835974** · NA · UNKNOWN · sponsor: **Assiut University** · enrollment: 120 (estimated)

## Conditions studied

- No-Reflow Phenomenon

## Interventions

- **DIAGNOSTIC_TEST:** 1- LDL-C (low-density lipoprotein cholesterol)| and HDL-C(high-density lipoprotein cholesterol) Ratio. 2- Glycemia will be assessed : RBS ( random blood sugar ) . 3- S

## Key facts

- **NCT ID:** NCT04835974
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-01
- **Primary completion:** 2022-05-01
- **Final completion:** 2022-05
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2021-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04835974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04835974, "the No-reflow in Diabetic Patients Treated With Primary Percutaneous Coronary Intervention (PCI)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04835974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*